Patents by Inventor Peter M. Eimon

Peter M. Eimon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12697350
    Abstract: The invention relates generally to modified tRNAs and the use of modified tRNAs to express in a mammalian cell a functional gene product encoded by a gene containing a premature termination codon and/or to treat a disease mediated by a premature termination codon, e.g., Dravet syndrome.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: August 4, 2026
    Assignee: Tevard Biosciences, Inc.
    Inventors: Sean McFarland, Ying-Hsin Chen, Peter M. Eimon
  • Publication number: 20240384300
    Abstract: The invention relates generally to expression vectors and pharmaceutical compositions comprising a first, second, and/or third modified tRNA and the use of expression vectors and pharmaceutical compositions to express in a mammalian cell a functional gene product encoded by a gene containing a premature termination codon and/or to treat a disorder mediated by a premature termination codon, e.g., Dravet syndrome.
    Type: Application
    Filed: May 5, 2022
    Publication date: November 21, 2024
    Inventors: Peter M. Eimon, Sean McFarland
  • Publication number: 20240148772
    Abstract: The invention relates generally to modified tRNAs and the use of modified tRNAs to express in a mammalian cell a functional gene product encoded by a gene containing a premature termination codon and/or to treat a disease mediated by a premature termination codon, e.g., Dravet syndrome.
    Type: Application
    Filed: October 30, 2020
    Publication date: May 9, 2024
    Inventors: Sean McFarland, Ying-Hsin Chen, Peter M. Eimon